246 related articles for article (PubMed ID: 15520058)
1. Palliative chemotherapy for advanced gastric cancer.
Wöhrer SS; Raderer M; Hejna M
Ann Oncol; 2004 Nov; 15(11):1585-95. PubMed ID: 15520058
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for advanced gastric cancer.
Wagner AD; Syn NL; Moehler M; Grothe W; Yong WP; Tai BC; Ho J; Unverzagt S
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD004064. PubMed ID: 28850174
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for advanced gastric cancer.
Wagner AD; Unverzagt S; Grothe W; Kleber G; Grothey A; Haerting J; Fleig WE
Cochrane Database Syst Rev; 2010 Mar; (3):CD004064. PubMed ID: 20238327
[TBL] [Abstract][Full Text] [Related]
4. Irinotecan in the treatment of gastric cancer.
Bugat R
Ann Oncol; 2003; 14 Suppl 2():ii37-40. PubMed ID: 12810456
[TBL] [Abstract][Full Text] [Related]
5. Palliative chemotherapy for recurrent and metastatic esophageal cancer.
Grünberger B; Raderer M; Schmidinger M; Hejna M
Anticancer Res; 2007; 27(4C):2705-14. PubMed ID: 17695436
[TBL] [Abstract][Full Text] [Related]
6. [Progress in chemotherapy for advanced gastric cancer].
Xu RH; Teng KY
Ai Zheng; 2009 Oct; 28(10):1108-13. PubMed ID: 19799823
[TBL] [Abstract][Full Text] [Related]
7. Is there an optimal chemotherapy regimen for the treatment of advanced gastric cancer that will provide a platform for the introduction of new biological agents?
Pozzo C; Barone C
Oncologist; 2008 Jul; 13(7):794-806. PubMed ID: 18614586
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of docetaxel or epirubicin, combined with cisplatin and fluorouracil (DCF and ECF), regimens as first line chemotherapy for advanced gastric cancer: a retrospective analysis from Turkey.
Teker F; Yilmaz B; Kemal Y; Kut E; Yucel I
Asian Pac J Cancer Prev; 2014; 15(16):6727-32. PubMed ID: 25169516
[TBL] [Abstract][Full Text] [Related]
9. Experience with docetaxel in the treatment of gastric cancer.
Philip PA
Semin Oncol; 2005 Apr; 32(2 Suppl 4):S24-38. PubMed ID: 16015552
[TBL] [Abstract][Full Text] [Related]
10. Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis.
Kim HS; Kim HJ; Kim SY; Kim TY; Lee KW; Baek SK; Kim TY; Ryu MH; Nam BH; Zang DY
Ann Oncol; 2013 Nov; 24(11):2850-4. PubMed ID: 23942775
[TBL] [Abstract][Full Text] [Related]
11. Gastric cancer. Treatment of advanced disease and new drugs.
Caponigro F; Facchini G; Nasti G; Iaffaioli RV
Front Biosci; 2005 Sep; 10():3122-6. PubMed ID: 15970566
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre study.
Brieau B; Auzolle C; Pozet A; Tougeron D; Bouché O; Soibinet P; Coriat R; Prieux C; Lecomte T; Goujon G; Marthey L; Rougier P; Bonnetain F; Ducreux M; Taieb J; Zaanan A
Dig Liver Dis; 2016 Apr; 48(4):441-5. PubMed ID: 26775096
[TBL] [Abstract][Full Text] [Related]
13. [Clinical development of chemotherapy for advanced gastric cancer].
Sato A; Matsukawa M
Nihon Shokakibyo Gakkai Zasshi; 2007 Feb; 104(2):186-93. PubMed ID: 17283412
[No Abstract] [Full Text] [Related]
14. Second-line chemotherapy for advanced gastric cancer in Korea.
Baek SK; Kim SY; Jeong JH; Cho KS; Yoon HJ
Gastric Cancer; 2012 Oct; 15(4):345-54. PubMed ID: 22410800
[TBL] [Abstract][Full Text] [Related]
15. Developments in the treatment of gastric cancer in Europe.
Köhne CH; Wils JA; Wilke HJ
Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):22-5. PubMed ID: 11200144
[TBL] [Abstract][Full Text] [Related]
16. Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.
Chu Q; Vincent M; Logan D; Mackay JA; Evans WK;
Lung Cancer; 2005 Dec; 50(3):355-74. PubMed ID: 16139391
[TBL] [Abstract][Full Text] [Related]
17. [The choice of treatment in advanced gastric cancer].
Pozzo C; Mansueto G
Tumori; 2007; 93(6):suppl 11-21. PubMed ID: 18338512
[No Abstract] [Full Text] [Related]
18. Efficacy and safety of first-line systemic chemotherapy with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil regimens in locally advanced inoperable or metastatic gastric or gastroesophageal junction adenocarcinoma: A prospective phase II study from South India.
Babu KG; Chaudhuri T; Lakshmaiah KC; Dasappa L; Jacob LA; Babu M; Rudresha AH; Lokesh KN; Rajeev LK
Indian J Cancer; 2017; 54(1):47-51. PubMed ID: 29199662
[TBL] [Abstract][Full Text] [Related]
19. Systemic treatment of gastric cancer.
Dickson JL; Cunningham D
Eur J Gastroenterol Hepatol; 2004 Mar; 16(3):255-63. PubMed ID: 15195888
[TBL] [Abstract][Full Text] [Related]
20. Salvage chemotherapy with irinotecan and cisplatin in patients with metastatic gastric cancer failing both 5-fluorouracil and taxanes.
Park SH; Choi EY; Bang SM; Cho EK; Lee JH; Shin DB; Ki Lee W; Chung M
Anticancer Drugs; 2005 Jul; 16(6):621-5. PubMed ID: 15930889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
